102 related articles for article (PubMed ID: 7685421)
1. Neoadjuvant hormonal deprivation in patients with locally advanced prostate cancer.
Macfarlane MT; Abi-Aad A; Stein A; Danella J; Belldegrun A; deKernion JB
J Urol; 1993 Jul; 150(1):132-4. PubMed ID: 7685421
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant hormonal therapy prior to radical prostatectomy: evaluation of pathological downstaging and biochemical relapse.
Kiriyama I; Ogaki K; Ohba S; Nishimura T
J Nippon Med Sch; 2002 Oct; 69(5):422-7. PubMed ID: 12382001
[TBL] [Abstract][Full Text] [Related]
3. Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects.
Gleave ME; Goldenberg SL; Chin JL; Warner J; Saad F; Klotz LH; Jewett M; Kassabian V; Chetner M; Dupont C; Van Rensselaer S;
J Urol; 2001 Aug; 166(2):500-6; discussion 506-7. PubMed ID: 11458055
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant hormonal therapy in stage C adenocarcinoma of the prostate.
Andros EA; Danesghari F; Crawford ED
Clin Invest Med; 1993 Dec; 16(6):510-5. PubMed ID: 7516835
[TBL] [Abstract][Full Text] [Related]
5. Experience with neoadjuvant diethylstilboestrol and radical prostatectomy in patients with locally advanced prostate cancer.
Aprikian AG; Fair WR; Reuter VE; Sogani P; Herr H; Russo P; Sheinfeld J
Br J Urol; 1994 Nov; 74(5):630-6. PubMed ID: 7530128
[TBL] [Abstract][Full Text] [Related]
6. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant hormonal deprivation before radical prostatectomy.
Sassine AM; Schulman CC
Eur Urol; 1993; 24 Suppl 2():46-50. PubMed ID: 7505231
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant androgen blockade prior to prostatectomy: a retrospective study and critical review.
Schulman CC
Prostate Suppl; 1994; 5():9-14. PubMed ID: 7513532
[TBL] [Abstract][Full Text] [Related]
9. Preoperative androgen deprivation therapy: artificial lowering of serum prostate specific antigen without downstaging the tumor.
Oesterling JE; Andrews PE; Suman VJ; Zincke H; Myers RP
J Urol; 1993 Apr; 149(4):779-82. PubMed ID: 7681117
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and biological evaluation of the response to neoadjuvant hormone therapy before radiotherapy in nonmetastatic cancers of the prostate].
Richaud P; Salem N; Gaston R; Mauriac L; Chacon B; Bussières E
Cancer Radiother; 1998; 2(1):27-33. PubMed ID: 9749093
[TBL] [Abstract][Full Text] [Related]
11. Downstaging of localized prostate cancer by neoadjuvant therapy with flutamide and lupron: the first controlled and randomized trial.
Labrie F; Dupont A; Cusan L; Gomez J; Diamond P; Koutsilieris M; Suburu R; Fradet Y; Lemay M; Têtu B
Clin Invest Med; 1993 Dec; 16(6):499-509. PubMed ID: 8013155
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer.
Laverdière J; Gomez JL; Cusan L; Suburu ER; Diamond P; Lemay M; Candas B; Fortin A; Labrie F
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):247-52. PubMed ID: 9069293
[TBL] [Abstract][Full Text] [Related]
13. Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer. The Lupron Depot Neoadjuvant Prostate Cancer Study Group.
Soloway MS; Sharifi R; Wajsman Z; McLeod D; Wood DP; Puras-Baez A
J Urol; 1995 Aug; 154(2 Pt 1):424-8. PubMed ID: 7541859
[TBL] [Abstract][Full Text] [Related]
14. Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapy.
Zelefsky MJ; Lyass O; Fuks Z; Wolfe T; Burman C; Ling CC; Leibel SA
J Clin Oncol; 1998 Oct; 16(10):3380-5. PubMed ID: 9779716
[TBL] [Abstract][Full Text] [Related]
15. Hormone therapy prior to radical prostatectomy in patients with clinical stage C prostate cancer.
Voges GE; Mottrie AM; Stöckle M; Müller SC
Prostate Suppl; 1994; 5():4-8. PubMed ID: 7513531
[TBL] [Abstract][Full Text] [Related]
16. Downstaging by combination therapy with flutamide and an LHRH agonist before radical prostatectomy.
Labrie F; Cusan L; Gomez JL; Diamond P; Suburu R; Lemay M; Têtu B; Fradet Y; Candas B
Cancer Surv; 1995; 23():149-56. PubMed ID: 7621455
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of suramin, leuprolide, and flutamide in previously untreated metastatic prostate cancer.
Dawson NA; Figg WD; Cooper MR; Sartor O; Bergan RC; Senderowicz AM; Steinberg SM; Tompkins A; Weinberger B; Sausville EA; Reed E; Myers CE
J Clin Oncol; 1997 Apr; 15(4):1470-7. PubMed ID: 9193342
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant hormonal deprivation for patients undergoing radical prostatectomy.
Gao X; Zhou T; Tang YJ; Lu X; Sun YH
Asian J Androl; 2009 Jan; 11(1):127-30. PubMed ID: 19050694
[TBL] [Abstract][Full Text] [Related]
19. Treatment of localized prostate cancer with intermittent triple androgen blockade: preliminary results in 110 consecutive patients.
Leibowitz RL; Tucker SJ
Oncologist; 2001; 6(2):177-82. PubMed ID: 11306729
[TBL] [Abstract][Full Text] [Related]
20. Radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation: Five-year results.
Homma Y; Akaza H; Okada K; Yokoyama M; Moriyama N; Usami M; Hirao Y; Tsushima T; Sakamoto A; Ohashi Y; Aso Y;
Int J Urol; 2004 May; 11(5):295-303. PubMed ID: 15147545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
